[Seven-day omeprazole, clarithromycin, and amoxicillin for the therapy of Helicobacter pylori infection]. 1998

R Comet, and X Calvet, and M Navarro, and N García, and I Sanfeliu
Servicio de Medicina Intern Consorci Hospitalari del Parc Taulí, Sabadell, Barcelona.

BACKGROUND There are few series reporting efficacy of seven-day therapy with omeprazole, amoxicillin and clarithromycin for cure of Helicobacter pylori infection in Spain. The aim of the present study was to evaluate the efficacy of this treatment to eradicate H. pylori infection. METHODS One hundred consecutive patients with peptic ulcer disease and H. pylori infection were evaluated for eradication therapy between January and November 1996. Four of them were excluded because of reported penicillin allergy. The remaining 96 patients received a seven days course of omeprazole 20 mg/12h, clarithromycin 500 mg/12h and amoxicillin 1 g/12h. The efficacy of the treatment was evaluated at 2-4 months after therapy either by endoscopic biopsy or by 13C urea breath-test. RESULTS Seventy-eight patients were found to be cured at the control evaluation. Intention to treat analysis showed a cure rate of 81.3% (95% CI: 74-89%). Per protocol analysis showed a cure rate of 85.7% (95% CI: 79-93%)--78 out of 91 patient who returned for follow-up-. Compliance with the treatment was good in 94.5% of patients. Five patients presented mild side effects (diarrhea, abdominal pain, oral candidiasis and metallic taste). None of them had to interrupt the treatment. CONCLUSIONS Seven-day therapy with omeprazole, amoxicillin and clarithromycin achieves a 85% cure rate of H. pylori infection in our area.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009853 Omeprazole A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. H 168-68,Omeprazole Magnesium,Omeprazole Sodium,Prilosec,H 168 68,H 16868,Magnesium, Omeprazole,Sodium, Omeprazole
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000658 Amoxicillin A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration. Hydroxyampicillin,Actimoxi,Amoxicillin Anhydrous,Amoxicillin Monopotassium Salt,Amoxicillin Monosodium Salt,Amoxicillin Sodium,Amoxicillin Trihydrate,Amoxicillin, (R*)-Isomer,Amoxicilline,Amoxil,Amoxycillin,BRL-2333,Clamoxyl,Clamoxyl G.A.,Clamoxyl Parenteral,Penamox,Polymox,Trimox,Wymox,BRL 2333,BRL2333

Related Publications

R Comet, and X Calvet, and M Navarro, and N García, and I Sanfeliu
December 1996, Zhonghua nei ke za zhi,
R Comet, and X Calvet, and M Navarro, and N García, and I Sanfeliu
September 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie,
R Comet, and X Calvet, and M Navarro, and N García, and I Sanfeliu
November 2002, Scandinavian journal of gastroenterology,
R Comet, and X Calvet, and M Navarro, and N García, and I Sanfeliu
June 1998, Helicobacter,
R Comet, and X Calvet, and M Navarro, and N García, and I Sanfeliu
March 1998, Helicobacter,
R Comet, and X Calvet, and M Navarro, and N García, and I Sanfeliu
May 2001, Alimentary pharmacology & therapeutics,
R Comet, and X Calvet, and M Navarro, and N García, and I Sanfeliu
June 1996, Alimentary pharmacology & therapeutics,
R Comet, and X Calvet, and M Navarro, and N García, and I Sanfeliu
January 2001, Arquivos de gastroenterologia,
R Comet, and X Calvet, and M Navarro, and N García, and I Sanfeliu
March 2003, Revista espanola de enfermedades digestivas,
Copied contents to your clipboard!